James J. CAMPBELL
17Patents
3h-index
36Co-inventors
60Inventor score
Filing activity: Mar 16, 1979 → Nov 16, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6245332A | Modulation of systemic memory T cell trafficking | Human Necessities | 36 | Expired |
| US11304952B2 | Combination therapy using a chemokine receptor 2 (CCR2) antagonist and a PD-1/PD-L1 inhibitor | Human Necessities | 6 | Active |
| US4246583A | Multimode feed for a monopulse radar | Electricity | 4 | Expired |
| US9787210B2 | Precharging apparatus and power converter | Electricity | 3 | Active |
| US11045469B2 | Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C-C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies | Chemistry; Metallurgy | 3 | Active |
| US8658133B2 | Methods and compositions relating to alzheimer's disease | Physics | 2 | Active |
| US11154556B2 | Methods of treating solid tumors with CCR2 antagonists | Human Necessities | 2 | Active |
| US8506957B2 | Methods and compositions for monitoring progression of huntington's disease | Physics | 1 | Active |
| US11020394B2 | Compositions and methods for treating inflammatory bowel disease using a combination therapy of small molecule inhibitors of C—C chemokine receptor type 9 (CCR9) and anti-α4β7 integrin blocking antibodies | Chemistry; Metallurgy | 1 | Active |
| US11464786B2 | CXCR7 inhibitors for the treatment of cancer | Chemistry; Metallurgy | 1 | Active |
| US10792360B1 | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-TNF-alpha blocking antibodies | Chemistry; Metallurgy | 1 | Active |
| US11207294B2 | Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 | Human Necessities | 1 | Active |
| US11883391B2 | Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies | Human Necessities | 0 | Active |
| US11684606B2 | Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2 | Human Necessities | 0 | Active |
| US11986466B2 | Methods of treating solid tumors with CCR2 antagonists | Human Necessities | 0 | Active |
| US9028801B2 | Diagnosis of neurodegenerative diseases | Physics | 0 | Active |
| US6881406B2 | Modulation of systemic memory T cell trafficking | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.